Related Experiment Video
Updated: Feb 21, 2026

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
The association analysis between Glucose-6-Phosphate dehydrogenase deficiency and susceptibility to common diseases
De-Feng Liang1, Xue Li2, Wen-Lin Guo3
1Department of Emergency, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou, Guangdong, China.
Insights
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is linked to higher risks of autoimmune diseases, congenital heart defects, and type 1 diabetes in children. This finding highlights G6PD deficiency
Area of Science:
- Pediatric Medicine
- Genetics
- Immunology
- Cardiology
Background:
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common inherited enzyme disorder.
- The association between G6PD deficiency and susceptibility to pediatric diseases requires further investigation.
Purpose of the Study:
- To investigate the relationship between G6PD deficiency and the risk of developing common pediatric diseases.
- To identify specific pediatric conditions associated with G6PD deficiency in a large cohort of children.
Main Methods:
- Retrospective analysis of hospitalized children undergoing G6PD screening.
- Data collected from January 2019 to March 2024 at Guangzhou Women and Children's Medical Center.
- Statistical analysis of G6PD deficiency prevalence across various pediatric conditions in males and females.
Main Results:
- In males, G6PD deficiency was significantly associated with nephritis, allergic purpura, patent ductus arteriosus, atrial septal defect, ventricular septal defect, and type 1 diabetes.
- In females, G6PD deficiency showed significant associations with systemic lupus erythematosus (SLE), juvenile arthritis, nephritis, patent ductus arteriosus, atrial septal defect, and ventricular septal defect.
- The study identified a novel association between G6PD deficiency and an increased incidence of congenital heart disease in children.
Conclusions:
- G6PD deficiency may increase the risk of autoimmune diseases, congenital heart defects, and type 1 diabetes in pediatric populations.
- The findings suggest G6PD deficiency impacts immune and cardiovascular systems, extending beyond its role as an enzymatic defect.
- Further research is warranted to elucidate the precise mechanisms and inform clinical management strategies for G6PD-deficient children.
Background:
This study investigates the relationship between G6PD deficiency and susceptibility to common pediatric diseases.
Methods:
A retrospective analysis was conducted on hospitalized children who underwent G6PD screening at the Guangzhou Women and Children's Medical Center from January 2019 to March 2024.
Results:
Among 36,619 children, 20,662 were male. The prevalence of G6PD deficiency in males was significantly higher in conditions such as nephritis (OR 2.43,95%CI 1.45-4.21), allergic purpura (OR 2.24, 95%CI 1.24-4.09), patent ductus arteriosus (OR 2.04, 95%CI 1.32-3.33), atrial septal defect (OR 2.14, 95%CI 1.41-3.45), ventricular septal defect (OR 1.73, 95%CI 1.12-2.80), and type 1 diabetes (OR 2.04, 95%CI 1.16-3.66). Among 15,957 female patients, the prevalence of G6PD deficiency was significantly elevated in systemic lupus erythematosus (SLE) (OR 1.87, 95%CI 1.27-2.70), juvenile arthritis (OR 1.79, 95%CI 1.16-2.68), nephritis (OR 1.72, 95%CI 1.16-2.49), patent ductus arteriosus (OR 1.27, 95%CI 1.00-1.61), atrial septal defect (OR 1.33, 95%CI 1.10-1.61), and ventricular septal defect (OR 1.55, 95%CI 1.26-1.91).
Conclusion:
G6PD deficiency may increase the risk of autoimmune diseases, congenital heart defects, and type 1 diabetes in children. Further studies are required to elucidate its role in pediatric disease susceptibility and inform clinical management.
Impact:
1. This study found that G6PD deficiency is significantly associated with increased susceptibility to several common pediatric diseases, including autoimmune diseases, congenital heart defects, and type 1 diabetes. Notably, in both male and female patients, G6PD deficiency was significantly linked to specific conditions, such as SLE, juvenile arthritis, and congenital heart disease. 2. Our findings indicate that G6PD deficiency is not merely an enzymatic defect but may also impact the immune and cardiovascular systems. Specifically, an increased incidence of congenital heart disease has been observed in children with G6PD deficiency for the first time.
Related Concept Videos
Inborn Errors of Metabolism
Pedigree Analysis
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Genetic Lingo

